Search Ontology:
ChEBI

ceftaroline fosamil

Term ID
CHEBI:70718
Synonyms
  • (6R,7R)-7-({(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino)-3-{[4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
  • 7-({(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino)-3-{[4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl}-3,4-didehydrocepham-4-carboxylate
  • ceftarolina fosamilo
  • ceftaroline fosamil
  • ceftarolinum fosamilum
Definition
A cephalosporin having [4-(1-methylpyridinium-4-yl)-1,3-thiazol-2-yl]sulfanyl and {(2Z)-2-(ethoxyimino)-2-[5-(phosphonoamino)-1,2,4-thiadiazol-3-yl]acetyl}amino side groups located at positions 3 and 7 respectively. The N-phospho prodrug of ceftaroline, a broad-spectrum antibiotic active against methicillin-resistant Staphylococcus aureus (MRSA). It is used for the treatment of adults with acute bacterial skin and skin structure infections.
References
  • cas:229016-73-3
  • drugcentral:4169
  • patent:MX2012003411
  • pubmed:21076711
  • pubmed:21115453
  • pubmed:21115454
  • pubmed:21115455
  • pubmed:21115456
  • pubmed:21162631
  • pubmed:21252841
  • pubmed:21393213
  • pubmed:21482565
  • pubmed:21482566
  • pubmed:21482568
  • pubmed:21482570
  • pubmed:21548186
  • pubmed:21897727
  • pubmed:22058102
  • pubmed:22314524
  • pubmed:22330908
  • pubmed:22354289
  • pubmed:22355258
  • pubmed:22594846
  • pubmed:22779432
  • pubmed:22903949
  • pubmed:22985880
  • pubmed:29017833
  • reaxys:9535806
  • wikipedia.en:Ceftaroline_fosamil
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from ceftaroline fosamil
Phenotype where environments contain ceftaroline fosamil
Phenotype modified by environments containing ceftaroline fosamil
Phenotype affecting ceftaroline fosamil
Human Disease Model